申请人:Takeda Pharmaceutical Company Limited
公开号:EP3287441A1
公开(公告)日:2018-02-28
The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).
本发明涉及一种化合物,该化合物可用于治疗或预防与 SPT 有关的疾病,包括癌症和与鞘脂蓄积有关的先天性疾病(包括尼曼-皮克病)。